患者在随机临床试验背景下对阿片类药物风险沟通的感知
这项定性研究纳入36名因肌肉骨骼性背痛/颈痛或肾结石相关疼痛就诊于美国4个急诊科的患者,均来自一项随机临床试验的两个风险干预组。干预分别为概率性阿片类药物风险工具或叙事增强的概率性风险工具(观看8个1-3分钟患者讲述疼痛治疗及阿片使用正负经历的短视频)。访谈于2019年6月4日至8月6日进行,2019年8月至12月进行主题分析,提炼出5个主题:风险干预相关因素、临床医生家长式作风、镇痛属性与既往经历、个体自我认同/态度/价值观、对临床医生偏见的感知。多数参与者表示从风险干预中学到深刻教训;作者认为需要更多研究理解患者如何将风险信息纳入决策过程。
要点
- 在急诊就诊后疼痛决策场景中,36名患者接受概率性风险工具或叙事增强版风险工具干预,多数人反馈从干预中获得深刻教训。
- 定性分析提炼5个影响决策的主题:风险干预相关因素、临床医生家长式作风、镇痛属性与既往经历、自我认同/态度/价值观、对临床医生偏见的感知。
- 研究纳入18-70岁、因肌肉骨骼性背/颈痛或肾结石相关疼痛就诊、24小时内可出院、能使用邮件或智能手机的成人。
- 作者认为需要更多研究理解患者如何将风险信息纳入决策过程。
适用人群与场景
- 美国4个地理分布不同的急诊科中,因肌肉骨骼性背痛或颈痛或肾结石相关疼痛就诊的成人。
- 纳入标准:年龄18至70岁、能提供知情同意、英语会话或英语理解、入组后24小时内符合急诊出院条件、能访问电子邮件或智能手机。
处置流程与药物剂量
- 参与者从主随机临床试验中入组,接受两种风险干预之一:概率性阿片类药物风险工具,或叙事增强的概率性风险工具(观看8个1至3分钟的患者讨论疼痛治疗及阿片使用正负经历的短视频)。
研究设计与关键结果
- 定性研究纳入36名患者,概率性风险工具单独组18人,附加叙事增强概率性风险工具组18人;中位年龄38岁(范围21-67岁),女性22人(61%),黑人或非裔美国人14人(39%),白人14人(39%)。
- 访谈于2019年6月4日至2019年8月6日进行,2019年8月至12月采用混合归纳与演绎方法进行主题分析。
- 分析得出5个主题域:风险干预相关因素;临床医生家长式作风;镇痛属性与既往经历;个体自我认同、态度和价值观;对临床医生偏见的感知。
- 多数参与者评论从风险干预中学到的深刻教训。
证据类型、等级与局限
- 证据类型:定性研究(对随机临床试验参与者的访谈)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为需要更多研究来理解患者如何将风险信息纳入其决策过程。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Opioid overdose rates continue to increase, and extant literature suggests that many individuals who use heroin were first introduced to opioids through a medical prescription.
OBJECTIVE: To explore patient experiences related to decisions regarding analgesia after an emergency department visit within the context of a randomized clinical trial aimed to test the efficacy of risk communication interventions on treatment preference, risk recall, and use of opioids.
DESIGN, SETTING, AND PARTICIPANTS: This qualitative study of 36 patients making decisions regarding analgesia included qualitative interviews with participants in 2 risk intervention groups. Interviews were audio recorded, transcribed, and edited to remove identifying information to protect the confidentiality of participants. Interviews were conducted from June 4, 2019, to August 6, 2019. We conducted thematic analysis from August to December 2019 using a mixed inductive and deductive approach. Participants received $20 in compensation. The study was conducted in 4 geographically diverse emergency departments in the United States. Participants were adults presenting to the emergency department with either musculoskeletal back or neck pain or kidney stone-related pain. Eligibility criteria included being aged 18 to 70 years, capable of providing informed consent, English speaking or having English comprehension, eligible for emergency department discharge within 24 hours of enrollment, and able to access email or a smartphone.
INTERVENTIONS: Participants enrolled from the main randomized clinical trial received 1 of 2 risk interventions: a probabilistic opioid risk tool or a narrative-enhanced probabilistic risk tool (ie, participants viewed eight 1- to 3-minute short videos of patients discussing their experiences with pain treatment and positive and negative experiences with opioid use).
MAIN OUTCOMES AND MEASURES: Factors reported by participants to have influenced their decision-making regarding acute pain and treatment.
RESULTS: Thirty-six participants were interviewed, 18 in the group who received the probabilistic risk tool alone and 18 in the group who received the additional narrative-enhanced probabilistic risk tool intervention. The median age was 38 years (range, 21-67 years), 22 individuals were female (61%), 14 were Black or African American (39%), and 14 were White (39%). Five themes emerged from the analysis in the following domains: the factors associated with the risk interventions; clinician paternalism; analgesia attributes and previous experiences; individual self-identity, attitudes, and values; and perceptions of clinician bias.
CONCLUSIONS AND RELEVANCE: Most participants commented on the powerful lessons they learned from the risk interventions. More research is needed to understand how patients incorporate risk information into their decision-making process.
参考来源
- Dolan AR, Goldberg EB, Cannuscio CC, et al. Patient Perceptions About Opioid Risk Communications Within the Context of a Randomized Clinical Trial. JAMA Netw Open. 2022. PMID: 35980634. doi:10.1001/jamanetworkopen.2022.27650
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。